SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Indications -- cardiovascular -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (20)1/28/2002 12:08:32 PM
From: keokalani'nui  Respond to of 214
 
>>Novartis would grab cpb indication long time ago if they think that it is worth risk.<<

Have read comments that issue was not clinical efficacy risk, but molecule's manufacturing cost.

Wilder